Microbot Medical® Receives Fda 510(k) Clearance for Its Liberty® Endovascular Robotic System

Microbot’s Liberty Endovascular Robotic System Cleared by FDA - Endovascular Today

September 8, 2025—Microbot Medical Inc. announced FDA 510(k) clearance was granted for the single-use, remotely operated Liberty endovascular robotic system for peripheral endovascular procedures. According to the company, the Liberty pivotal study demonstrated 100% success in robotic navigation to the target and zero device-related adverse events. The study also showed a 92% relative reduction in radiation exposure for physicians. The company a…

Microbot Medical receives US FDA 510(k) clearance for Liberty endovascular robotic system - Interventional News

Microbot Medical today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Liberty system, the first FDA cleared single use, remotely operated robotic system for peripheral endovascular procedures, states the company in a recent press release. The FDA clearance positions the company to commercialise Liberty in the US, with the goal of transforming the field to enable accessibility to advanced robotics wi…

FDA clears Microbot’s LIBERTY endovascular robot

The US Food and Drug Administration (FDA) has cleared Microbot’s LIBERTY, a single-use, remotely operated robotic system for peripheral endovascular procedures.The post FDA clears Microbot’s LIBERTY endovascular robot appeared first on Medical Device Network.

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Open the article to view the coverage from dailyguardian.ca

Microbot Medical Receives FDA 510 Clearance for Its LIBERTY® Endovascular Robotic System

Green Stock News for the New Green Economy.